Erdem Göker

19PUBLICATIONS
161CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 28, 2026
Comparison of Neoadjuvant TCHP and ddAC+THP Regimens for Pathologic Complete Response in HER2-Positive Breast Cancer: A Multicenter Real-World Analysis of Systemic Inflammatory Biomarkers.

|May 13, 2026
Prominent Lymphovascular Space Invasion as an Independent Prognostic Factor in LVSI-Positive Endometrioid Endometrial Carcinoma: Evidence for a Novel Three-Tiered Classification.

|May 04, 2026
Serum Carcinoembryonic Antigen Levels Across Molecular Subtypes and Their Clinical and Prognostic Implications in Metastatic Non-Small Cell Lung Cancer.

|Apr 20, 2026
Evaluating oral nutritional support and the nutritional risk scores in ICI-treated metastatic solid tumours.

|Feb 11, 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group.

Salih Tunbekici, Hamit Bal, Oguzcan Kınıkoglu

|Feb 09, 2026
Folic acid-conjugated biopolymeric nanoparticles for targeted delivery of ixabepilone in breast cancer.

Ayça Mehmetoğlu Al, İskender İnce, Erkan Kahraman

Pageof 4

Frequent Collaborators

7 joint publications

Gökhan Şahin

6 joint publications

Caner Acar

6 joint publications

Haydar Cagatay Yuksel

4 joint publications

Burçak Karaca